Glanzmann's thrombasthenia diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2].
'''Platelet aggregation assays''' — Traditional platelet aggregation assays employ a panel of platelet agonists to measure platelet activation and aggregation in vitro. Either whole blood or platelet-rich plasma is used depending on the technique. Since many common medications can affect platelet function, care must be taken to avoid their use in patients prior to testing. Common agonists used in these assays include ADP, arachidonic acid, collagen, epinephrine, thrombin, and ristocetin. Platelet function testing", section on 'Platelet aggregometry'.)


== Diagnostic study of choice ==
== Diagnostic study of choice ==
There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2].
There is no single diagnostic study of choice for the diagnosis of Glanzmann's thrombasthenia, but it can be diagnosed based on '''Platelet aggregation assays''' — Traditional platelet aggregation assays employ a panel of platelet agonists to measure platelet activation and aggregation in vitro. Either whole blood or platelet-rich plasma is used depending on the technique. Since many common medications can affect platelet function, care must be taken to avoid their use in patients prior to testing. Common agonists used in these assays include ADP, arachidonic acid, collagen, epinephrine, thrombin, and ristocetin. (See "Platelet function testing", section on 'Platelet aggregometry'.)


==References==
==References==

Revision as of 22:37, 20 November 2018

Glanzmann's thrombasthenia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glanzmann's thrombasthenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glanzmann's thrombasthenia diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glanzmann's thrombasthenia diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glanzmann's thrombasthenia diagnostic study of choice

CDC on Glanzmann's thrombasthenia diagnostic study of choice

Glanzmann's thrombasthenia diagnostic study of choice in the news

Blogs on Glanzmann's thrombasthenia diagnostic study of choice

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Glanzmann's thrombasthenia diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2], Niyousha Danesh, MD-MPH

Overview

Platelet aggregation assays — Traditional platelet aggregation assays employ a panel of platelet agonists to measure platelet activation and aggregation in vitro. Either whole blood or platelet-rich plasma is used depending on the technique. Since many common medications can affect platelet function, care must be taken to avoid their use in patients prior to testing. Common agonists used in these assays include ADP, arachidonic acid, collagen, epinephrine, thrombin, and ristocetin. Platelet function testing", section on 'Platelet aggregometry'.)

Diagnostic study of choice

There is no single diagnostic study of choice for the diagnosis of Glanzmann's thrombasthenia, but it can be diagnosed based on Platelet aggregation assays — Traditional platelet aggregation assays employ a panel of platelet agonists to measure platelet activation and aggregation in vitro. Either whole blood or platelet-rich plasma is used depending on the technique. Since many common medications can affect platelet function, care must be taken to avoid their use in patients prior to testing. Common agonists used in these assays include ADP, arachidonic acid, collagen, epinephrine, thrombin, and ristocetin. (See "Platelet function testing", section on 'Platelet aggregometry'.)

References